Making Curative Treatment Decisions in Breast Cancer: How Precise Need We Be?

This talk discusses how clinicians make recommendations with patients, predominantly focusing on systemic therapies such as which endocrine therapy to use, how long to use it, and deciding when a patient needs chemotherapy.

DR BELINDA YEO
Medical Oncologist 
Austin Hospital


Despite an increasing incidence of breast cancer in Australia, most women will be cured of their disease with multimodality therapy. Many treatment decisions need to be made in a relative short period of time. This talk discusses how clinicians make those recommendations with patients, predominantly focusing on systemic therapies such as which endocrine therapy to use, how long to use it, and deciding when a patient needs chemotherapy.

Dr Belinda Yeo is jointly appointed to the Austin Hospital in Melbourne, Australia, as a Medical Oncologist and to the Olivia Newton-John Cancer Research Institute as a Clinician Scientist with a specific interest in breast cancer.  She trained in Sydney before joining the Breast Unit at The Royal Marsden Hospital, London as a Clinical and Research Fellow. She completed a Master’s Degree at The University of London and The Institute of Cancer Research in novel genomic and non-molecular breast cancer risk assays. She is co-lead of the VCCC Research and Education Stream for Breast Cancer, she is a clinical trial investigator and continues her translational research investigating improving personalization and minimising toxicities for patients with breast cancer.